|Study Participants||Healthcare Professionals||Researchers||Locations||Publications||What is TrialNet?||News and Events||Get Screened!||Home|
TrialNet News Archive
TrialNet Goes to Camp! Many camps are offering a risk screening for families of campers. Learn More >
Type 1 Diabetes TrialNet was recently featured in the ADA's Diabetes Forecast. Read About it
USA Weekend featured TrialNet in ParentSmart
FOX News featured a story on TrialNet's Natural History Study.
The popular Jonas Brothers band and their mother, Denise Jonas, join TrialNet researchers to get an important message to family members of people with type 1 diabetes. Learn More >
Nashville's NewsChannel5 features TrialNet's abatacept trial in the their article: Putting The Brakes On Diabetes
The Indy Channel (Indianapolis, IN), February 2008
ABC7 (San Francisco), January 2008:
ABC News, November 2007:When a child is diagnosed with juvenile diabetes, also known as Type 1 diabetes, the most serious form of the disease, routines and priorities change.
Pittsburgh Tribune-Review, November 2007:
WBAL-11 TV (Baltimore, MD), November 2007: (Video)
NBC6 (South Florida), November 2007:
Researchers at the University of Miami are studying a new treatment that could better maintain type 1 diabetes.
Approximately 85,000 people in El Paso have diabetes, according to the El Paso Diabetes Association.
"There are not many diseases like this where you have the hope of actually preventing them from happening," said Dave Gould, the parents of three kids with type 1 diabetes.
Now, for the first time, Indiana University researchers are turning to a cancer drug called rituximab to see if it can increase insulin production. Researchers are testing the cancer drug on recently diagnosed type-one diabetes patients who are at least eight years old.
[T]he Mahoneys are attempting to halt the disease before it starts. They've joined a study with Boston's Joslin Diabetes Center examining the possibly preventative role that Omega-3 fatty acids -- also called docosahexaenoic acid, or DHA -- might play in the development of type 1 diabetes.
The Davis Center, part of the University of Colorado Health Sciences Center, is one of dozens of sites around the world trying to find out whether regular doses of oral insulin can stop a strong propensity for diabetes from turning into the disease.
Type 1 diabetes has a formidable new enemy: A global network of diabetes researchers, immunology experts, and specialized laboratories and facilities is pooling resources to understand—and hopefully prevent—type 1 diabetes.
Researchers to screen relatives for type 1 diabetes risk factors
Penn State Diabetes Center Research Newsletter (Vol. 1, No. 2, 2005):
This research study is ongoing at many centers around the world and screens relatives of people with type 1 diabetes to see if they are also at risk. If you have type 1 diabetes, do you want to know if your children are at risk? Does your sibling or cousin have type 1 diabetes and do you worry that you may be next? Then this study may be for you. And, in the near future, this study will include experimental diabetes prevention treatments as well.